Tetanus toxoid vaccine companies focus on the development and production of vaccines to prevent tetanus infections. These companies contribute to public health by providing immunization solutions that induce protective immunity against tetanus, a bacterial disease commonly associated with wounds and injuries.
Latest Tetanus toxoid vaccine Companies Updates:
Jan 2024
Serum Institute of India Expanded their production capacity for tetanus toxoid vaccine to meet the needs of global immunization programs, particularly in low- and middle-income countries.Collaborated with Gavi, the Vaccine Alliance, to provide affordable tetanus vaccines for children and pregnant women in developing countries.
Sanofi Pasteur Received FDA approval for their next-generation tetanus toxoid vaccine with improved stability and shelf life, enabling its use in challenging environments.Introduced a combination vaccine containing tetanus toxoid, diphtheria toxoid, and acellular pertussis antigen for simplified childhood immunization schedules.
Bharat Biotech International Ltd Developed a novel nasal spray vaccine containing tetanus toxoid for potential needle-free and painless immunization, particularly beneficial for children and needle-phobic individuals.Partnered with academic institutions to conduct clinical trials on the nasal spray vaccine's efficacy and safety.
Merck & Co.,Launched an educational campaign highlighting the importance of tetanus booster vaccinations for adults and pregnant women.Collaborated with healthcare providers to improve tetanus vaccination rates and awareness of its life-saving benefits.
World Health Organization (WHO) Established a new global goal to eliminate tetanus as a public health threat by 2030.Launched initiatives to strengthen surveillance systems, improve vaccine delivery infrastructure, and combat vaccine hesitancy.
List of Tetanus toxoid vaccine Key companies in the market:
Tetanus Toxoid Vaccine Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)